Physician profile
Patrick H Dang
NPI 1629268214
$1,221.67
in general payments reported to CMS, 2019-2025
17 companies · $106 in 2025
The $106 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.08 · 2020: $85.08 · 2021: $178 · 2022: $259 · 2023: $287 · 2024: $217 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $610.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $265.82 | 2019-2025 | Rybelsus, Ozempic |
| Abbvie INC. | $208.90 | 2020-2025 | Ubrelvy |
| Astrazeneca Pharmaceuticals Lp | $175.94 | 2021-2024 | Airsupra, Breztri |
| Abbott Laboratories | $105.18 | 2023-2024 | Freestyle Libre 3, Freestyle Libre 2 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $90.68 | 2019-2024 | Trulance, Xifaxan |
| Kowa Pharmaceuticals America, INC. | $82.78 | 2022-2023 | Livalo, Seglentis |
| Gilead Sciences, INC. | $62.30 | 2019-2021 | |
| Tolmar, INC. | $41.98 | 2023-2024 | |
| Pfizer INC. | $32.83 | 2021-2023 | |
| Glaxosmithkline, LLC. | $28.47 | 2021 | |
| Adlon Therapeutics L.P. | $21.88 | 2021 | |
| Hologic Sales and Service, LLC | $21.58 | 2022 | |
| Genentech USA, INC. | $18.64 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.51 | 2023 | Quviviq |
| Pharmacosmos Therapeutics INC. | $17.17 | 2023 | Monoferric |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $17.07 | 2024 | Zepbound |
| Emd Serono, INC. | $12.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Dang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.